Abiopharma

Martin Patricia A. 🟢 acquired 3.6K shares of AN2 Therapeutics, Inc. (ANTX) Transaction Date: Jan 12, 2026 | Filing ID: 013038

Marks Gilbert Lynn 🟢 acquired 11.6K shares of AN2 Therapeutics, Inc. (ANTX) Transaction Date: Jan 12, 2026 | Filing ID: 013035

New Form SCHEDULE 13G/A - FENNEC PHARMACEUTICALS INC. Filed: 2026-01-14 AccNo: 0001012975-26-000043 Size: 15 KB

Alam Kamran 🟢 acquired 590.0K shares (1 derivative) of Taysha Gene Therapies, Inc. (TSHA) at $4.86 ($1.1M) Transaction Date: Jan 12, 2026 | Filing ID: 000002

Nolan Sean P. 🟢 acquired 1.7M shares (1 derivative) of Taysha Gene Therapies, Inc. (TSHA) at $4.86 ($3.1M) Transaction Date: Jan 12, 2026 | Filing ID: 000002

Nagendran Sukumar 🟡 adjusted position in 501.0K shares (3 derivative) of Taysha Gene Therapies, Inc. (TSHA) at $4.86 ($2.7M) Transaction Date: Jan 12, 2026 | Filing ID: 000002

VESEY MICHAEL 🔴 sold 18.1K shares of Forian Inc. (FORA) at $2.12 Transaction Date: Jan 12, 2026 | Filing ID: 001191

New Form SCHEDULE 13G - Erasca, Inc. Filed: 2026-01-14 AccNo: 0001104659-26-003756 Size: 15 KB

(90% Positive) Oramed Pharmaceuticals Inc. (ORMP) Announces Business Combination

(99% Neutral) Kiniksa Pharmaceuticals (KNSA) Announces New Board Appointment